Cymbalta lawsuits from excessive withdrawal symptoms and inadequate instructions
Because Eli Lilly, manufacturer of the psychiatric drug Cymbalta (duloxetine), has failed to provide adequate instruction as to properly taper the drug at discontinuation, thousands of patients across the country and around the world have faced serious withdrawal symptoms unnecessarily, prompting large numbers of Cymbalta withdrawal lawsuits. According to MedlinePlus, a medical encyclopedia curated by
